Table 4.
Lipid profile in different FT3 and BMI categories.
BMI < 25 | BMI ≥ 25 | |||||||
---|---|---|---|---|---|---|---|---|
Group 1 FT3 T1 |
Group 2 FT3 T2 |
Group 3 FT3 T3 |
P | Group 4 FT3 T1 |
Group 5 FT3 T2 |
Group 6 FT3 T3 |
P | |
TG | 1.05 (0.74–1.56) | 1.29 (0.90–1.84) | 1.55 (1.02–2.17) | 0.041 ∗ | 1.75 (1.13–2.60) | 1.88 (1.34–2.90) | 2.09 (1.40–3.06) | 0.687 |
CHOL | 4.72 ± 0.96 | 4.81 ± 0.95 | 4.92 ± 0.95 | 0.005 ∗∗ | 4.82 ± 0.87 | 4.97 ± 0.98 | 5.06 ± 0.94 | 0.004 ∗∗ |
HDL-C | 1.36 ± 0.33 | 1.32 ± 0.34 | 1.28 ± 0.32 | 0.613 | 1.16 ± 0.31 | 1.14 ± 0.28 | 1.19 ± 0.30 | 0.058 |
LDL-C | 2.86 ± 0.81 | 2.93 ± 0.81 | 3.06 ± 0.83 | 0.003 ∗∗ | 2.85 ± 0.77 | 3.03 ± 0.86 | 3.09 ± 0.82 | 0.004 ∗∗ |
We stratified the study group according to BMI levels: BMI < 25 kg/m2: normal-weight group; BMI ≥ 25 kg/m2: overweight/obese group. Then, we stratified each group according to serum FT3 levels; and all continuous parameters were presented as mean ± standard deviation, after adjustment for age and gender. For skewness distribution data, median and interquartile range was used. P values were calculated from ANOVA (analysis of variance, between categories), after adjustment for age and gender. Significant associations are indicated in bold. P < 0.05 was considered statistically significant. ∗P < 0.05, ∗∗P < 0.01.